Zageno, Inc.

Zageno, Inc. is a procurement software platform specializing in the biotech and pharmaceutical sectors, enabling seamless acquisition of laboratory supplies for researchers and procurement teams. Zageno, Inc. was founded in 2015 in Cambridge, US, with a focus on providing a comprehensive marketplace for lab supplies.

The firm has successfully completed 4 funding deals, with the latest round raising USD 33 mn on May 26, 2023, co-led by General Catalyst Partners, Grazia Equity, and OakRidge Management Group. The company was founded by David Pumberger, Florian Wegener, and Kilian Veer, with Florian Wegener currently serving as CEO. Zageno offers a comprehensive procurement software platform specifically designed for the biotech and pharmaceutical sectors, facilitating the acquisition of lab supplies. The platform serves as a marketplace where users can access over 40 million products from 5,300 global brands, allowing scientists and procurement teams to find, compare, and select supplies efficiently.

Key features include automated order tracking, consolidated invoicing, and AI-driven search capabilities that enhance the user experience and streamline the purchasing process. Zageno’s solutions are tailored to meet the needs of various roles within laboratory operations, including scientists and finance professionals, ultimately improving productivity and reducing administrative burdens. The company's services are marketed primarily in North America and Europe, catering to clients in research institutions, biotech firms, and pharmaceutical companies. Zageno generates revenue through its subscription-based procurement platform, which provides a streamlined purchasing experience for its clients.

The company’s business model focuses on B2B transactions, where clients, including research and development teams and procurement departments, access the platform to manage lab supply orders. Revenue is derived from transaction fees associated with each purchase made through the platform, as well as potential service fees for premium features such as advanced spend analytics and supplier management tools. The pricing structure is designed to optimize client spending and may include custom approval flows and purchase limits tailored to individual organizational needs. Zageno’s operational framework supports clients in achieving significant cost reductions, with reports indicating an average savings of 20-40% in operating costs.

In May 2023, Zageno, Inc. raised USD 33 mn in venture funding to expand its business reach and operations. The company plans to leverage this funding to enhance its platform offerings and explore potential new product launches, although specific details regarding new products and release dates have yet to be outlined. Additionally, Zageno aims to enter new geographic markets, focusing on further expansion within North America and Europe to better serve its clients in the biotech and pharmaceutical industries.